MTT assay outcomes in both the FOXD2-AS1-silenced and FOXD2-AS1-overexpressing cell lines revealed that FOXD2-AS1 was involved in positive regulation of bladder cancer cell viability (Fig. 2c, d, Fig. S1A). Here, FOXD2 is linked to urinary bladder carcinoma.